| Bioactivity | 3,6-Dihydroxyxanthone (compound 3) is a xanthone derivatives. 3,6-Dihydroxyxanthone (compound 3) has anticancer activity. 3,6-Dihydroxyxanthone (compound 3) can be used for cancer research[1]. |
| Invitro | 3,6-Dihydroxyxanthone (compound 3) (3.906-1000 µg/mL; 24 hours) exhibits cytotoxic activity against WiDR and Vero cell lines with IC50 values of 785.58 and 1280.9 µM[1]. Cell Cytotoxicity Assay[1] Cell Line: |
| Name | 3,6-Dihydroxyxanthone |
| CAS | 1214-24-0 |
| Formula | C13H8O4 |
| Molar Mass | 228.20 |
| Appearance | Solid |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, stored under nitrogen *In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen) |
| Reference | [1]. Miladiyah I, et, al. Biological activity, quantitative structure-activity relationship analysis, and molecular docking of xanthone derivatives as anticancer drugs. Drug Des Devel Ther. 2018 Jan 15;12:149-158. |
3,6-Dihydroxyxanthone
CAS: 1214-24-0 F: C13H8O4 W: 228.20
3,6-Dihydroxyxanthone (compound 3) is a xanthone derivatives. 3,6-Dihydroxyxanthone (compound 3) has anticancer activity
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.